Clinical trials
Recruiting Phase 3 Lupus Erythematosus, Systemic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2024 | 4 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| EMD Serono Research & Development Institute, Inc. | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Beijing Mabworks Biotech Co., Ltd. | 1 |
| Janssen Research & Development, LLC | 1 |
| NYU Langone Health | 1 |
| Novartis Pharmaceuticals | 1 |
| UCB Biopharma SRL | 1 |
| Viatris Innovation GmbH | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Erythematosus, Systemic | 12 |
| Lupus Erythematosus, Cutaneous | 2 |
| Lupus Erythematosus, Discoid | 2 |
| Lupus Nephritis | 2 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.